End-stage renal disease in diabetic persons: Is the pandemic subsiding?

Kidney International

Volumn 70, Issue SUPPL. 104, 2006, Pages

  Friedman, E A ^a   Friedman, A L ^b   Eggers, P ^c  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Diabetes; End stage renal disease; Hypertension; Nephropathy; Pandemic; Renoprotection

Indexed keywords

DIABETES MELLITUS; DIABETIC PATIENT; HUMAN; INCIDENCE; KIDNEY FAILURE; LIFESTYLE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RENAL PROTECTION; REVIEW; SOCIOECONOMICS; UNITED STATES; ARTICLE; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; EPIDEMIC; PUBLIC HEALTH SERVICE; STATISTICS;

CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); DIABETIC NEPHROPATHIES; DISEASE OUTBREAKS; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; UNITED STATES;

EID: 39049189516     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001978     Document Type: Article

References (27)

1. US Renal Data System, USRDS 2005 Annual Data Report. Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, 2005.
2. Friedman EA. Coping with the coming pandemic of renal failure due to diabetes mellitus. Facta Universitatis 2003; 1: 1-15.
3. Mauer SM, Chavers BM. A comparison of kidney disease in type I and type II diabetes. Adv Exp Med Biol 1985; 189: 299-303.
4. Morbidity and Mortality Weekly Report, Centers for Disease Control and Prevention, Atlanta, GA, November 4, 2005; 54: 1097-1100.
5. Miyata T, de Ypersele S. Renoprotection of angiotensin receptor blockers: beyond blood pressure lowering. Nephrol Dial Transplant 2006; 10: 1-4.
6. So WY, Ma RC, Ozaki R et al. Angiotensin-converting enzyme (ACE) inhibition in type 2, diabetic patients - interaction with ACE insertion/ deletion polymorphism. Kidney Int 2006; 69: 383-387.
7. American Diabetes Association. Clinical Practice Recommendations 2006, Standards of Medical Care in Diabetes - 2006. Hypertension/blood pressure control. Diabetes Care 2006; 29(Suppl 1): S17-S18.
8. Levey AS, Eckardt KU, Tsukamoto Y et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-2100.
9. Kong AP, So WY, Szeto CC et al. Assessment of glomerular filtration rate in addition to albuminuria is important in managing type II diabetes. Kidney Int 2006; 69: 383-387.
10. Bode BW, Schwartz S, Stubbs HA, Block JE. Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes: normative values. Diabetes Care 2005; 28: 2361-2366.
11. American Diabetes Associatioin. Clinical Practice Recommendations 2006, Standards of Medical Care in Diabetes -2006 Glycemic goals. Diabetes Care 2006; 29(Suppl 1): S11.
12. Dijkstra RF, Niessen LW, Braspenning JC et al. Patient-centred and professional-directed implementation strategies for diabetes guidelines: a cluster-randomized trial-based cost-effectiveness analysis. Diabetes Med 2006; 23: 164-170.
13. McCarter RJ, Hempe JM, Chalew SA. Mean blood glucose and biological variation have greater influence on HbA1c levels than glucose instability: an analysis of data from the Diabetes Control and Complications Trial. Diabetes Care 2006; 29: 352-355.
14. Clarke PM, Gray AM, Briggs A, et al. UKPDS 72 United Kingdom Prospective Diabetes Study. Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72). Diabetologia 2005; 48: 868-877.
15. Benner D. K/DOQI gets to the heart of managing dyslipidemias in patients with CKD. Nephrol Nurs J 2005; 32: 337-338.
16. Ridderstrale M, Gudbjornsdottir S, Eliasson B et al. for the Steering Committee of the Swedish National Diabetes Register (NDR). Obesity and cardiovascular risk factors in type 2 diabetes: results from the Swedish National Diabetes Register. J Intern Med 2006; 259: 314-322.
17. Thomas MC, Rosengard-Barlund M, Mills V et al. Serum lipids and the progression of nephropathy in type 1 diabetes. Diabetes Care 2006; 29: 317-322.
18. American Diabetes Associatioin. Clinical Practice Recommendations 2006, Standards of Medical Care in Diabetes - 2006. Dysllipidemia/lipid management. Diabetes Care 2006; 29(Suppl 1): S18-S19.
19. Nilsson PM, Gudbjornsdottir S, Eliasson B, Cederholm J. Steering Committee of the Swedish National Diabetes Register. Smoking is associated with increased HbA1c values and microalbuminuria in patients with diabetes - data from the National Diabetes Register in Sweden. Diabetes Metab 2004; 30: 261-268.
20. De Nicola L, Minutolo R, Chiodini P et al. Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int 2006; 69: 538-545.
21. Evans N, Forsyth E. End-stage renal disease in people with type 2 diabetes: systemic manifestations and exercise implications. Phys Ther 2004; 84: 454-463.
22. Ritz E, Schwenger V. Lifestyle modification and progressive renal failure. Nephrology (Carlton) 2005; 10: 387-392.
23. Enserink M. Influenza: new study casts doubt on plans for pandemic containment. Science 2006; 24: 311-1084.
24. Dowdle WR. Influenza pandemic periodicity, virus recycling, and the art of risk assessment. Emerg Infect Dis 2006; 12: 34-39.
25. US Renal Data System, USRDS 2005 Annual Data Report. Atlas of End-Stage Renal Disease in the United States,. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, 2005. Cumulative percent of diabetic patients with CVD receiving ACE-Is/ARBs, by age & ESRD status, figure 5.26, p 114, Cumulative percent of diabetic patients with CVD receiving lipid-lowering treatment, by age & ESRD status, figure 5.29, p 115.
26. American Diabetes Association. Standards of Medical Care in Diabetes - 2006. Diabetes Care 2006(Suppl 1): S11-S13.
27. Kaufman M. Smoking in US declines sharply. Cigarette sales at a 54-year low. Wasington Post, 9 March 2006, p A01.